Prothena Corp. plc Stock
Prothena Corp. plc Stock
Prothena Corp. plc gained 3.000% today.
We see a rather positive sentiment for Prothena Corp. plc with 12 Buy predictions and 1 Sell predictions.
As a result the target price of 15 € shows a very positive potential of 62.97% compared to the current price of 9.2 € for Prothena Corp. plc.
For the coming years our community has positive and negative things to say abot the Prothena Corp. plc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Prothena Corp. plc in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prothena Corp. plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | 3.000% | 2.190% | 10.035% | 46.431% | 16.073% | -86.688% | -54.240% |
| Heron Therapeutics Inc. | -0.570% | 3.235% | 54.512% | -50.424% | -5.476% | -47.871% | -92.305% |
| Evolus Inc | 0.110% | 15.568% | 50.757% | -48.757% | -3.156% | -30.553% | -28.190% |
| Sangamo Therapeutics Inc. | 50.930% | 35.092% | -41.262% | -71.434% | -56.089% | -87.325% | -98.221% |
Comments
Prothena (PRTA) had its "outperform" rating reaffirmed by Citigroup Inc..
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) had its price target raised by analysts at HC Wainwright from $20.00 to $30.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat
Prothena (NASDAQ:PRTA) was given a new $20.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
Show more
Ratings data for PRTA provided by MarketBeat